Results 251 to 260 of about 88,754 (289)
Some of the next articles are maybe not open access.
Abstract Orphan drug designation for the EU, UK, and USA is described, highlighting the requirements and potential incentives on offer for development of medicines for patients with rare diseases.
Phil Ambery +2 more
+4 more sources
Phil Ambery +2 more
+4 more sources
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti, 2001
The paper discusses the problems of orphan drugs from the standpoint of the attitude of state authorities in the USA, Japan, and particularly Europe (the European Union) to their definition and the formation of appropriate legislation--financial provision for the development, production, provision of exclusive sale rights--which warranties the ...
J, Kolár, M, Chalabala, H, Srámková
openaire +1 more source
The paper discusses the problems of orphan drugs from the standpoint of the attitude of state authorities in the USA, Japan, and particularly Europe (the European Union) to their definition and the formation of appropriate legislation--financial provision for the development, production, provision of exclusive sale rights--which warranties the ...
J, Kolár, M, Chalabala, H, Srámková
openaire +1 more source
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
Modern developments in germline pharmacogenomics for oncology prescribing
Ca-A Cancer Journal for Clinicians, 2022Natalie M Reizine, Peter H O'donnell
exaly